Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

NCT06826430 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Thrombocytopenia

Interventions

DRUG: Inaticabtagene autoleucel Injection

Sponsor

Juventas Cell Therapy Ltd.